Relationships between serum resistin and fat intake, serum lipid concentrations and adiposity in the general population

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 5, 2014, Pages 454-462

  de León, Antonio Cabrera ^a,b,c   González, Delia Almeida ^a,c   Hernández, Ana González ^a,c   Coello, Santiago Domínguez ^a,c   Marrugat, Jaume ^c,d   Sánchez, José Juan Alemán ^a,c   Díaz, Buenaventura Brito ^a,c   Rodríguez, Itahisa Marcelino ^a,c   Pérez, María del Cristo Rodríguez ^a,c  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Adiposity; Fat intake; Lipids; Population; References; Resistin

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; FAT INTAKE; LIPID;

ADULT; AGE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FAT INTAKE; FEMALE; GENDER; HUMAN; LIPID BLOOD LEVEL; MALE; MEDITERRANEAN DIET; OBESITY; PROTEIN EXPRESSION; WAIST CIRCUMFERENCE; ADMINISTRATION AND DOSAGE; ADOLESCENT; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIET THERAPY; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; PHYSIOLOGY; PROGNOSIS; RISK FACTOR; SPAIN; YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ADULT; AGED; BIOMARKERS; CROSS-SECTIONAL STUDIES; DIET, MEDITERRANEAN; DIETARY FATS; FEMALE; HUMANS; INCIDENCE; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; RESISTIN; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 84901502273     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.22103     Document Type: Article

References (42)

1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes, Nature, 2001; 409: 307-312
2. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun, 2003; 309: 286-290
3. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA: An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1. 2004. e45
4. Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP: Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab, 2007; 92: 2272-2279
5. Korah TE, Ibrahim HH, Badr EA, ElShafie MK: Serum resistin in acute myocardial infarction patients with and without diabetes mellitus. Postgrad Med J, 2011; 87: 463-467
6. Kreçki R, Krzeminska-Pakuła M, Peruga JZ, Szczesniak P, Lipiec P, Wierzbowska-Drabik K, Orszulak-Michalak D, Kasprzak JD: Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multivessel coronary artery disease over 1-year follow-up. Med Sci Monit, 2011; 17: CR26-CR32
7. Cabrera de León A, Almeida González D, González Hernández A, Alemán Sánchez JJ, Brito Díaz B, Domínguez Coello S, Marcelino Rodríguez I, Oliva García JG, Aguirre Jaime A, Rodríguez Pérez MC: The association of resistin and coronary disease in the general population. J Atheroscler Thromb. Accepted, 2013
8. Zhang MH, Na B, Schiller NB, Whooley MA: Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study. J Card Fail, 2011; 17: 24-30
9. Lee TS, Lin CY, Tsai JY, Wu YL, Su KH, Lu KY, Hsiao SH, Pan CC, Kou YR, Hsu YP, Ho LT: Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages. Life Sci, 2009; 84: 97-104
10. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature, 2010; 464: 1357-1361
11. De Nardo D, Latz E: NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol, 2011; 32: 373-379
12. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I, van den Berg S, Romijn J, Rensen PC, Joosten LA, Netea MG, Kanneganti TD: Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A, 2011; 108: 15324-29
13. Piestrzeniewicz K, Łuczak K, Komorowski J, Maciejewski M, Jankiewicz Wika J, Goch JH: Resistin increases with obesity and atherosclerotic risk factors in patients with myocardial infarction. Metabolism, 2008; 57: 488-493
14. Iqbal N, Seshadri P, Stern L, Loh J, Kundu S, Jafar T, Samaha FF: Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci, 2005; 9: 161-165
15. Filková M, Haluzík M, Gay S, Senolt L: The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol, 2009; 133: 157-170
16. Libby P: Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med, 2013; 368: 2004-2013
17. Malo E, Ukkola O, Jokela M, Moilanen L, Kähönen M, Nieminen MS, Salomaa V, Jula A, Kesäniemi YA: Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish Health 2000 survey. Metab Syndr Relat Disord, 2011; 9: 203-210
18. Cabrera de León A, Rodríguez Pérez MC, Almeida González D, Domínguez Coello S, Aguirre Jaime A, Brito Díaz B, González Hernández A, Pérez Méndez LI; grupo CDC. Presentation of the "CDC de Canarias" cohort: objectives, design and preliminary results. Rev Esp Salud Pública, 2008; 82: 519-534
19. Hirsch G, Vaid N, Blumenthal RS: Perspectives: The significance of measuring non-HDL-cholesterol. Prev Cardiol, 2002; 5: 156-159
20. Aguirre-Jaime A, Cabrera de León A, Domínguez Coello S, Borges Alamo C, Carrillo Fernández L, Gavilán Batista JC, Rodríguez Pérez Mdel C, Almeida González D: Validation of a food intake frequency questionnaire adapted for the study and monitoring of the adult population of the Canary Islands, Spain. Rev Esp Salud Publica. 2008; 82: 509-518
21. Willet WC, Howe GR, Kushi LH: Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr, 1997; 65: 1220S-1228S
22. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D: Adherence to a Mediterranean Diet and Survival in a Greek Population. N Engl J Med, 2003; 348: 2599-2608
23. Bamia C, Lagiou P, Buckland G, Grioni S, Agnoli C, Taylor AJ, Dahm CC, Overvad K, Olsen A, Tjønneland A, Cottet V, Boutron-Ruault MC, Morois S, Grote V, Teucher B, Boeing H, Buijsse B, Trichopoulos D, Adarakis G, Tumino R, Naccarati A, Panico S, Palli D, Buenode- Mesquita HB, van Duijnhoven FJ, Peeters PH, Engeset D, Skeie G, Lund E, Sánchez MJ, Barricarte A, Huerta JM, Quirós JR, Dorronsoro M, Ljuslinder I, Palmqvist R, Drake I, Key TJ, Khaw KT, Wareham N, Romieu I, Fedirko V, Jenab M, Romaguera D, Norat T, Trichopoulou A: Mediterranean diet and colorectal cancer risk: results from a European cohort. Eur J Epidemiol, 2013; 28: 317-328
24. Barbaresko J, Koch M, Schulze MB, Nöthlings U: Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutr Rev, 2013; 71: 511-527
25. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Martínez- González MA; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med, 2013; 368: 1279-1290
26. Heggen E, Klemsdal TO, Haugen F, Holme I, Tonstad S: Effect of a low-fat versus a low-glycemic-load diet on inflammatory biomarker and adipokine concentrations. Metab Syndr Relat Disord, 2012; 10: 437-442
27. Urpi-Sarda M, Casas R, Chiva-Blanch G, Romero- Mamani ES, Valderas-Martínez P, Arranz S, Andres- Lacueva C, Llorach R, Medina-Remón A, Lamuela- Raventos RM, Estruch R: Virgin olive oil and nuts as key foods of the Mediterranean diet effects on inflammatory biomakers related to atherosclerosis. Pharmacol Res, 2012; 65: 577-583
28. Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-Zacas D, Mantzoros CS: Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab, 2003; 88: 1730-1736
29. Kushiyama A, Sakoda H, Oue N, Okubo M, Nakatsu Y, Ono H, Fukushima T, Kamata H, Nishimura F, Kikuchi T, Fujishiro M, Nishiyama K, Aburatani H, Kushiyama S, Iizuka M, Taki N, Encinas J, Sentani K, Ogonuki N, Ogura A, Kawazu S, Yasui W, Higashi Y, Kurihara H, Katagiri H, Asano T: Resistin-Like Molecule β Is Abundantly Expressed in Foam Cells and Is Involved in Atherosclerosis Development. Arterioscler Thromb Vasc Biol, 2013; 33: 1986-1993
30. Spieker LE, Sudano I, Hürlimann D, Lerch PG, Lang MG, Binggeli C, Corti R, Ruschitzka F, Lüscher TF, Noll G: High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation, 2002; 105: 1399-1402
31. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM: Antiinflammatory properties of HDL. Circ Res, 2004; 95: 764-772
32. Rezaee F, Casetta B, Levels JH, Speijer D, Meijers JC: Proteomic analysis of high-density lipoprotein. Proteomics, 2006; 6: 721-730
33. Vaisar T: Proteomics investigations of HDL. Challenges and promise. Curr Vasc Pharmacol, 2012; 10: 410-421
34. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL: Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol, 2007; 156: 279-284
35. Gupta V, Singh AK, Gupta V, Kumar S, Srivastava N, Jafar T, Pant B: Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome. Toxicol Int, 2011; 18: 168-172
36. Korah TE, Ibrahim HH, Badr EA, ElShafie MK: Serum resistin in acute myocardial infarction patients with and without diabetes mellitus. Postgrad Med J, 2011; 87: 463-467
37. Gruendel S, Weickert MO, Garcia AL, Wagner K, Pfeiffer AF, Harsch I, Koebnick C: Serum resistin increases in a postprandial state during liquid meal challenge test in healthy human subjects. J Endocrinol Invest, 2006; 29: RC27-30
38. Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE: Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis, 2010; 69: 1310-1314
39. Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Dahlqvist SR: Up-Regulation of Cytokines and Chemokines Predates the Onset of Rheumatoid Arthritis. Arthritis Rheum, 2010; 62: 383-391
40. Navarro-Millán I, Charles-Schoeman C, Yang S, Bathon JM, Bridges SL Jr, Chen L, Cofield SS, Dell'italia LJ, Moreland LW, O'Dell JR, Paulus HE, Curtis JR: Changes in lipoproteins associated with methotrexate or combina-tion therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum, 2013; 65: 1430-1438
41. Rodríguez Pérez MC, Cabrera de León A, Aguirre-Jaime A, Domínguez Coello S, Brito Díaz B, Almeida González D, Borges Alamo C, Castillo Rodríguez JC, Carrillo Fernández L, González Hernández A, Alemán Sánchez JJ: El cociente abdomen/estatura como índice antropométrico de riesgo cardiovascular y de diabetes. Med Clin (Barc), 2010; 134: 386-391
42. Ashwell M, Gunn P, Gibson S: Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev, 2012; 13: 275-286